Pharmaceutical Practice Group

Understanding Your Business

Pharmaceutical companies operate in a highly regulated, capital-intensive environment where speed to market, compliance, and talent access are critical. Shifting R&D models, supply chain pressures, and evolving regulatory and ESG expectations are driving more strategic approaches to real estate and facilities planning.

What Our Clients Are Facing

Evolving R&D and Innovation Models
Pharmaceutical research is increasingly collaborative, decentralized, and technology-driven. Companies require flexible laboratory, office, and innovation spaces that support discovery, clinical development, and partnerships.

Manufacturing and Supply Chain Resilience
Global supply chain disruption and regulatory scrutiny are driving renewed focus on domestic manufacturing, redundancy, and distribution efficiency — all of which influence site selection and long-term facility planning.

Regulatory and Quality Compliance
Strict FDA, GMP, and safety requirements shape every real estate decision, from laboratory design and production facilities to controlled storage and distribution environments.

Talent Competition
Access to scientific, technical, and manufacturing talent is a key driver of location strategy. Real estate must support collaboration, safety, and work environments that attract and retain highly specialized professionals.

Cost, Capital, and Portfolio Optimization
Pharmaceutical companies must balance significant capital investment with flexibility. Long development timelines and market uncertainty increase the importance of scalable, risk-managed real estate strategies.

How We Support Pharmaceutical Clients

We help pharmaceutical companies use real estate to support innovation, compliance, and operational performance. Our team partners with clients to:

• Develop location and facility strategies aligned with R&D, manufacturing, and distribution needs

• Identify and evaluate laboratory, office, and production facilities

• Navigate zoning, regulatory, and compliance-driven site requirements

• Structure leases and transactions that balance capital efficiency and flexibility

• Support portfolio optimization as business needs evolve

Our approach is strategic, disciplined, and client-focused — helping pharmaceutical organizations make real estate decisions that support growth, innovation, and long-term value.